Jay Whelan

438 total citations
20 papers, 337 citations indexed

About

Jay Whelan is a scholar working on Molecular Biology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Jay Whelan has authored 20 papers receiving a total of 337 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 8 papers in Cancer Research and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Jay Whelan's work include Cancer, Hypoxia, and Metabolism (6 papers), Metabolism, Diabetes, and Cancer (5 papers) and Cancer Mechanisms and Therapy (3 papers). Jay Whelan is often cited by papers focused on Cancer, Hypoxia, and Metabolism (6 papers), Metabolism, Diabetes, and Cancer (5 papers) and Cancer Mechanisms and Therapy (3 papers). Jay Whelan collaborates with scholars based in United States. Jay Whelan's co-authors include Dallas R. Donohoe, Ahmed Bettaieb, Yi Zhao, Anna Han, Julia S. Gouffon, J. Bruce German, Megan Johnstone, J. Jason Collier, Alexis D. Smith and Michael F. McEntee and has published in prestigious journals such as The FASEB Journal, Free Radical Biology and Medicine and International Journal of Molecular Sciences.

In The Last Decade

Jay Whelan

19 papers receiving 334 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jay Whelan United States 10 203 89 51 41 39 20 337
Zhenxiong Liu China 11 203 1.0× 64 0.7× 45 0.9× 34 0.8× 38 1.0× 19 361
Xiaomei Duan China 13 209 1.0× 113 1.3× 37 0.7× 36 0.9× 17 0.4× 21 413
Giuseppina Augimeri Italy 15 252 1.2× 149 1.7× 69 1.4× 50 1.2× 63 1.6× 33 551
Hamid Behrouj Iran 13 353 1.7× 122 1.4× 30 0.6× 52 1.3× 31 0.8× 27 562
Mostafa M. Elshafey Egypt 10 179 0.9× 160 1.8× 32 0.6× 34 0.8× 44 1.1× 14 450
Minnie Holmes‐McNary United States 4 220 1.1× 89 1.0× 48 0.9× 57 1.4× 56 1.4× 5 477
Vandana Singhal United States 9 239 1.2× 34 0.4× 41 0.8× 31 0.8× 30 0.8× 10 431
Shu Dai China 13 193 1.0× 61 0.7× 33 0.6× 86 2.1× 31 0.8× 24 452

Countries citing papers authored by Jay Whelan

Since Specialization
Citations

This map shows the geographic impact of Jay Whelan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jay Whelan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jay Whelan more than expected).

Fields of papers citing papers by Jay Whelan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jay Whelan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jay Whelan. The network helps show where Jay Whelan may publish in the future.

Co-authorship network of co-authors of Jay Whelan

This figure shows the co-authorship network connecting the top 25 collaborators of Jay Whelan. A scholar is included among the top collaborators of Jay Whelan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jay Whelan. Jay Whelan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Voy, Brynn H., et al.. (2023). Ginsenoside Rc from Panax Ginseng Ameliorates Palmitate-Induced UB/OC-2 Cochlear Cell Injury. International Journal of Molecular Sciences. 24(8). 7345–7345. 1 indexed citations
2.
Chahed, Samah, et al.. (2020). Zyflamend Induces Apoptosis in Pancreatic Cancer cells via Modulation of the JNK Pathway. The FASEB Journal. 34(S1). 1–1. 2 indexed citations
3.
Chahed, Samah, et al.. (2020). Zyflamend induces apoptosis in pancreatic cancer cells via modulation of the JNK pathway. Cell Communication and Signaling. 18(1). 126–126. 7 indexed citations
4.
5.
Donohoe, Dallas R., et al.. (2019). Pyruvate kinase M2: A simple molecule with complex functions. Free Radical Biology and Medicine. 143. 176–192. 127 indexed citations
6.
Donohoe, Dallas R., et al.. (2019). Decreased adiposity and enhanced glucose tolerance in Zyflamend treated mice. The FASEB Journal. 33(S1). 1 indexed citations
7.
Chahed, Samah, et al.. (2019). Zyflamend Induces Apoptosis in Pancreatic Cancer Cells via Modulation of the JNK Pathway. The FASEB Journal. 33(S1). 1 indexed citations
8.
Bettaieb, Ahmed, et al.. (2018). Concurrent regulation of LKB1 and CaMKK2 in the activation of AMPK in castrate-resistant prostate cancer by a well-defined polyherbal mixture with anticancer properties. BMC Complementary and Alternative Medicine. 18(1). 188–188. 12 indexed citations
9.
Han, Anna, et al.. (2018). Butyrate decreases its own oxidation in colorectal cancer cells through inhibition of histone deacetylases. Oncotarget. 9(43). 27280–27292. 41 indexed citations
10.
Bourdon, Allen K., Edward D. Kim, Wesley M. White, et al.. (2017). Metabolomics Approach in the Study of the Well-Defined Polyherbal Preparation Zyflamend. Journal of Medicinal Food. 21(3). 306–316. 6 indexed citations
11.
Han, Anna, et al.. (2017). Butyrate Regulates Its Own Metabolic Fate as an HDAC inhibitor in Colorectal Cancer Cells. The FASEB Journal. 31(S1). 1 indexed citations
12.
Johnstone, Megan, Alexis D. Smith, Anna Han, et al.. (2016). Characterization of the Pro‐Inflammatory Cytokine IL‐1β on Butyrate Oxidation in Colorectal Cancer Cells. Journal of Cellular Biochemistry. 118(6). 1614–1621. 20 indexed citations
13.
Han, Anna, et al.. (2015). Cellular Metabolism and Dose Reveal Carnitine-Dependent and -Independent Mechanisms of Butyrate Oxidation in Colorectal Cancer Cells. Journal of Cellular Physiology. 231(8). 1804–1813. 21 indexed citations
14.
Whelan, Jay, Yi Zhao, & Dallas R. Donohoe. (2015). Polyherbal Supplements can Modify Energetics and Lipid Metabolism in Cancer Cells by Activating AMPK Signaling. The FASEB Journal. 29(S1).
15.
Zhao, Yi, et al.. (2015). Zyflamend, a polyherbal mixture, inhibits lipogenesis and mTORC1 signalling via activation of AMPK. Journal of Functional Foods. 18. 147–158. 5 indexed citations
16.
Zhao, Yi, Guoxun Chen, Seung Joon Baek, et al.. (2014). Zyflamend, a polyherbal mixture, down regulates class I and class II histone deacetylases and increases p21 levels in castrate-resistant prostate cancer cells. BMC Complementary and Alternative Medicine. 14(1). 68–68. 14 indexed citations
17.
18.
Zhao, Yi, et al.. (2014). Turmeric and Chinese goldthread synergistically inhibit prostate cancer cell proliferation and NF-kB signaling. Functional Foods in Health and Disease. 4(7). 312–312. 9 indexed citations
19.
Whelan, Jay, Julia S. Gouffon, & Yi Zhao. (2012). Effects of Dietary Stearidonic Acid on Biomarkers of Lipid Metabolism4. Journal of Nutrition. 142(3). 630S–634S. 34 indexed citations
20.
German, J. Bruce, et al.. (1996). Monoglycerides in membrane systems. Critical Reviews in Food Science and Nutrition. 36(8). 785–805. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhenxiong Liu Breakdown of academic impact, for papers by Xiaomei Duan Breakdown of academic impact, for papers by Giuseppina Augimeri Breakdown of academic impact, for papers by Hamid Behrouj Breakdown of academic impact, for papers by Mostafa M. Elshafey Breakdown of academic impact, for papers by Minnie Holmes‐McNary Breakdown of academic impact, for papers by Vandana Singhal Breakdown of academic impact, for papers by Shu Dai
Rankless by CCL
2026